Oncology

Out-of-pocket costs can lead to the reduced use of preventive services and increased use of preventive medications.

New treatment approach offers less severe side effects from chemotherapy.

Study finds incidence of post-traumatic stress symptoms in breast cancer patients to be underestimated.

Cell-based therapy shows promise in high-grade glioma.

Gene overexpressed in AML may offer new target for halting the spread of cancer.

Hops in beer contain antibacterial and anti-fungal properties, which could halt the growth of diseases.

Alcohol can affect estrogen in breast cancer cells and weakens the ability of drugs that halt proliferation.

Recent advances and updates in oncology and cancer drug development.

Herbal remedies such as stinging nettle, garlic, black cumin, and turmeric can cause harm during chemotherapy in some instances.

New technique uses chromatin as a way of identifying small molecule drugs for cancer.

Current standard treatment for advanced ovarian cancer is carboplatin, paclitaxel, and bevacizumab.

Macrophages can penetrate the surrounding walls that protect pancreatic cancer from chemotherapy.

Research supports weekly chemotherapy without bevacizumab in treating advanced ovarian cancer.

Tyverb and Herceptin combination shows significant promise treating HER2 positive breast cancer.

Quality of life and overall health concerns plague patients who survive cancer.

The bacteria porphyromonas gingivalis is found in 61% of patients with esophageal squamous cell carcinoma.

Radiotherapy and panobinostat show promise treating glioblastoma.

Significant side effects and the high cost of treatment only extend survival by a month in

Increased inflammation in obese women is thought to increase the risk of breast cancer.

Laser system allows temporary window in blood-brain barrier to effectively target glioblastoma.

Immune checkpoint blockades have shown long-term control of different types of cancer.

PET scans are not recommended for long-term monitoring of cancer recurrence.

Study suggests low dose chemotherapy that controls tumor growth instead of eradicating the disease may be a more effective long term treatment.

Recent advances and updates in oncology and cancer drug development.

Xalkori gives new option to patients with the rare and difficult to treat ROS-1 gene mutation in NSCLC.

Expanded use of crizotinib treats patients with ROS1-positive metastatic non–small cell lung cancer.

Harnessing T cells may lead to significant new cancer treatments.

Obesity carries increased risk for diabetes, cardiovascular disease, and lymphomas.